Searching for Lymphoma Clinical Trials?

The Lymphoma Research Foundation offers these suggestions for navigating the hundreds of lymphoma clinical trial options you may come across.

• Focus on what is important to you: Is traveling a restriction? Are you interested in a specific treatment option? Will you consider trials in early development?
• Explore the site’s frequently asked questions (FAQs), tools, and links for help.
• Try different ways of searching for trials: by condition, treatment, and key terms (relapsed, etc.).
• Conduct the search several times under general and specific criteria. This will give you practice and help access more possible results that apply.
• If the site asks a series of questions for creating a search profile, if possible, provide as much information as known. This will help narrow down results to those that apply to your situation.
• If available, create a registered account, which may allow you to save your search results. If this option is not available, add search results directly to your Internet provider’s list of favorites for later review.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap